These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


474 related items for PubMed ID: 11260531

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Paraneoplastic pemphigus mimicking erosive mucosal lichen planus associated with primary hepatocellular carcinoma.
    Yokokura H, Demitsu T, Kakurai M, Umemoto N, Azuma R, Yamada T, Suzuki M, Jimbu Y, Yoneda K, Ishii N, Hashimoto T.
    J Dermatol; 2006 Dec; 33(12):842-5. PubMed ID: 17169086
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Role of intramolecular epitope spreading in pemphigus vulgaris.
    Salato VK, Hacker-Foegen MK, Lazarova Z, Fairley JA, Lin MS.
    Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832
    [Abstract] [Full Text] [Related]

  • 47. Paraneoplastic pemphigus with circulating antibodies directed exclusively against the pemphigus vulgaris antigen desmoglein 3.
    Bouloc A, Joly P, Saint-Leger E, Wechsler J, Roujeau JC, Revuz J.
    J Am Acad Dermatol; 2000 Oct; 43(4):714-7. PubMed ID: 11004638
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome.
    Nagasaka T, Nishifuji K, Ota T, Whittock NV, Amagai M.
    J Clin Invest; 2004 Nov; 114(10):1484-92. PubMed ID: 15545999
    [Abstract] [Full Text] [Related]

  • 50. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
    Szabados H, Bősze S, Silló P, Kárpáti S, Hudecz F, Uray K.
    J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay.
    Mouquet H, Drenovska K, Lartigue A, Joly P, Drouot L, Thomas M, Tron F, Gilbert D.
    Clin Immunol; 2008 Nov; 129(2):304-12. PubMed ID: 18790674
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Paraneoplastic pemphigus presenting as erythrodermic lichenoid dermatitis with concomitant features of pemphigus foliaceus.
    Fukumoto T, Shiroyama Y, Niizeki H, Kobayashi N, Asada H, Ishii N, Hashimoto T, Miyagawa S.
    J Dermatol; 2007 Sep; 34(9):645-9. PubMed ID: 17727368
    [Abstract] [Full Text] [Related]

  • 56. Autoimmunity against desmosomal cadherins in pemphigus.
    Amagai M.
    J Dermatol Sci; 1999 Jun; 20(2):92-102. PubMed ID: 10379702
    [Abstract] [Full Text] [Related]

  • 57. Influence of intravenous immunoglobulin therapy on autoantibody titers to desmoglein 3 and desmoglein 1 in pemphigus vulgaris.
    Sami N, Bhol KC, Ahmed RA.
    Eur J Dermatol; 2003 Jun; 13(4):377-81. PubMed ID: 12948919
    [Abstract] [Full Text] [Related]

  • 58. Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression.
    Miyagawa S, Amagai M, Iida T, Yamamoto Y, Nishikawa T, Shirai T.
    Br J Dermatol; 1999 Dec; 141(6):1084-7. PubMed ID: 10606856
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.